Epstein-Barr Virus Market Likely to Exhibit Substantial Growth by 2032, Examines DelveInsight | Key Players in the Market - Viracta, Atara, AlloVir, ModernaTX, Immunitas, Schrödinger, VelosBio, Takeda, Gilead, Merck
GlobeNewswire
The dynamics of the Epstein–Barr virus (EBV) market are anticipated to change during the forecast period (2023–2032) owing to..